Milestone Scientific Inc ( (MLSS) ) has released its Q2 earnings. Here is a breakdown of the information Milestone Scientific Inc presented to its investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Milestone Scientific Inc., a Delaware-based company, specializes in developing computer-controlled anesthetic delivery devices for dental and medical applications, with a focus on innovative technology in the healthcare sector. In its latest earnings report for the quarter ended June 30, 2025, Milestone Scientific Inc. highlighted a net loss of $1.48 million, compared to a net income of $223,638 in the same quarter of the previous year. The company reported product sales of $2.32 million, a notable increase from $1.85 million in the same period last year, driven by a rise in dental segment sales. Despite an increase in gross profit to $1.62 million, the company faced higher operating expenses, which contributed to the overall loss. Milestone Scientific’s financial performance was impacted by increased selling, general, and administrative expenses, as well as research and development costs. The company continues to face challenges related to its cash flow and liquidity, with cash and cash equivalents decreasing to $1.27 million from $3.26 million at the end of 2024. Looking ahead, Milestone Scientific’s management remains focused on securing additional funding to support its operations and aims to enhance revenue generation from its dental and medical device segments, while also working to reduce operating expenses.